Antigen presenting cell targeted cancer vaccines

Details for Australian Patent Application No. 2010222930 (hide)

Owner Baylor Research Institute

Inventors Zurawski, Gerald; Banchereau, Jacques F.; Flamar, Anne-Laure; Montes, Monica; Klucar, Peter; Akagawa, Keiko

Agent Pizzeys

Pub. Number AU-A-2010222930

PCT Pub. Number WO2010/104749

Priority 12/717,778 04.03.10 US; 61/159,059 10.03.09 US; 61/159,055 10.03.09 US; 61/159,062 10.03.09 US

Filing date 4 March 2010

Wipo publication date 16 September 2010

International Classifications

C07K 19/00 (2006.01) Hybrid peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/104749 Priority application(s): WO2010/104749

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010222931-Processes for surface cleaning

2010222929-Antigen presenting cell targeted antiviral vaccines